February 04, 2025
Results of a phase II trial for intermediate-risk rhabdomyosarcoma treatment protocol...
Atsushi Kikuta, Hidekazu Masaki, Hiroshi Hojo, et al.
January 31, 2023
Hematopoietic Stem Cell Transplantation Based on Minimal Residual Disease with a Unif...
Hidemi Toyoda, Hideaki Ueki, Chitose Ogawa, et al.